Embeddedsoft Spółka z Ograniczoną Odpowiedzialnością (KRS 0000609012, NIP 7162818585) is a Polish company, headquartered in Falenty Nowe, Mazowieckie voivodeship. Embeddedsoft operates in: Scientific research and development (PKD 72.10.Z). Industry: Research and development. The company has been listed in the National Court Register since March 30, 2016. Embeddedsoft's most recently reported net revenue was 196.9 K PLN for 2023. Embeddedsoft's operations are currently suspended.
The company is currently suspended
Suspended since July 1, 2026
Negative equity
Negative equity in 5 of 6 available reporting years.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Business profile - Embeddedsoft
Identity
- Name
- Embeddedsoft Spółka z Ograniczoną Odpowiedzialnością
- Legal form
- Limited Liability Company (LLC)
- Founded
- March 30, 2016
- Registry status as of
- August 5, 2026
- Latest entry
- August 5, 2026
- Founding act
- 8 LUTEGO 2016 R. NOTARIUSZ ARNOLD CHRZANOWSKI KANCELARIA NOTARIALNA W SZCZEKOCINACH UL. ŚCIEGIENNEGO 25, 42-445 SZCZEKOC…
Articles of association history (2)
- 8 LUTEGO 2016 R. NOTARIUSZ ARNOLD CHRZANOWSKI KANCELARIA NOTARIALNA W SZCZEKOCINACH UL. ŚCIEGIENNEGO 25, 42-445 SZCZEKOCINY REPERTORIUM A 467/2016
- AKT NOTARIALNY Z DNIA 1 CZERWCA 2026 ROKU, REP. A 2833/2026, NOTARIUSZ ARNOLD CHRZANOWSKI, KANCELARIA NOTARIALNA W SZCZEKOCINACH, UL. STEFANA ŻEROMSKIEGO 70B, 42-445 SZCZEKOCINY. ZMIENIONO § 1 UST. 3 ORAZ § 2 UST. 2.
Activities
Other activities
Address and contact
- Address
- UL. SZAFRANOWA, 6, 05-090, FALENTY NOWE, POLSKA
- Voivodeship
- MAZOWIECKIE
- District
- PRUSZKOWSKI
- Not disclosed in the registry
- Website
- Not disclosed in the registry
- E-delivery address
- Not disclosed in the registry
Risk and payment profile - Embeddedsoft
Credibility rating
5 / 100
Very poor credibility
Insolvency risk
suspended
Significant formal threat
Closure risk
80
/ 100
Extremely high risk
Risk comparison - scale 0 (safe) → 100 (critical)
Organisational stability signals
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
2
2/10 yrs
Board changes
1
1/10 yrs
PKD changes
1
1/10 yrs
Name changes
0
0/10 yrs
Data from 10 years of registry activity.
Credibility history
Payment reliability score from 2018–2023
Current: S (5/100)
Trend: stable (0.0 pts/year)
Spółka jest obecnie zawieszona – działalność operacyjna wstrzymana, wskaźnik wiarygodności odzwierciedla stan przed zawieszeniem.
Trade credit limit history
Standard limit from 2018–2023
Current: 1.6 K PLN
Safe: 277.98 PLN
Operational status - Embeddedsoft
Founded
March 30, 2016
10 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
FALENTY NOWE
MAZOWIECKIE
Primary PKD
72.10.Z
Scientific research and development
Share capital
5.0 K PLN
50 shares total
Shareholders
2
shareholders
Board
1 person
Filed years
6 years
2018–2023 · profitable: 1/6
Registry entries
30
latest: August 5, 2026
Risk signals
Revenue
196.9 K PLN
2023
Net profit
-68.0 K PLN
2023
Assets
31.1 K PLN
2023
Equity
-2.1 M PLN
2023
EBITDA
-37.6 K PLN
2023
Valuation
0 PLN
suspended
Board and connected people - Embeddedsoft
People holding roles at Embeddedsoft according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
- Piotr Paweł BiegusPresident of the board, Majority shareholder
- Stefania BiegusVice president, Majority shareholder
- Grzegorz Józef BiegusBoard member
- Dominika Patrycja TabernackaCommercial proxy
Directories and rankings for this location
EU Funds
Projects co-financed by the European Union for Embeddedsoft - total value, EU contribution and the company's largest awards.
Projects
1
EU co-financing
48.0 K PLN
Total project value
73.8 K PLN
Eligible spending
60.0 K PLN
Funds
Operational programmes
- Regionalny Program Operacyjny Województwa Lubelskiego na lata 2014-2020
Largest projects
Top 1 by EU co-financing
| Project | Fund | EU co-financing | Value | Rate | Period |
|---|---|---|---|---|---|
Zgłoszenie patentowe konstrukcji oraz zasady działania SSM 3D |
Public procurement
Trademarks
Reviews
Rate business credibility - Embeddedsoft.
No ratings
Related articles
News
Bioceltix in the final EMA dialogue phase: BCX-CM-J could become Europe's first veterinary cell-therapy drug for dogs
Wrocław-based Bioceltix S.A. (KRS 0000744521) entered Q2 2026 in the final EMA dialogue phase on BCX-CM-J – potentially Europe's first veterinary cell-therapy drug based on mesenchymal stem cells, for dogs with osteoarthritis. Responses to the EMA's final questions are due in May 2026; a CVMP recommendation and marketing authorisation are possible in Q3/Q4 2026. A pre-commercial biotech: it closed 2024 with a PLN 14.9m loss on zero revenue and PLN 33.6m of cash at year-end. Trigon DM maintains a buy rating with a PLN 127.2 price target.
News
Captor Therapeutics: PLN 36m of cash at 30 September 2025, runway to mid-2026 – clinical data versus the cash clock
Wrocław-based Captor Therapeutics S.A. (KRS 0000756383) – a pre-commercial biotech specialising in targeted protein degradation (TPD) – closed Q3 2025 with PLN 36m of cash and grants securing funding to mid-2026. CT-01 (hepatocellular carcinoma) entered Phase I, with the first patient dosed at the Barcelona Clinic Liver Cancer. CT-03, an MCL-1 degrader, is close to clinical entry. Without a new R&D partnership or share issue in 2026, the company will need additional financing.